Immunochemical analysis relies on the selective binding of antibodies to de
fined targets such as environmental compounds. Commercial applications in t
he environmental field are still restricted to a limited number of immunoas
says and a few immunochromatographic applications. The main barrier to a br
oader exploitation is seen in the generation of a sufficient number of anti
bodies within an acceptable time period. Recombinant technologies are expec
ted to eventually replace the circumstantial approach to obtain new Abs by
new immunizations. Examples for recombinant singlechain fragments (scFv) an
d antigen binding fragments (Fab) directed against herbicidal s-triazines a
re given. If antibodies are replaced by receptors and other functional liga
nds, biological effects monitoring becomes available. As an example an enzy
me-linked receptor assay (ELRA) for endocrine disrupters providing estrogen
equivalents is presented. Finally, the concept of bioresponse-linked instr
umental analysis is introduced for the tight coupling of effect monitoring
to chemical analysis. In the first step, analyte binding by functional biom
olecules is recorded to provide binding equivalents. The second step is tar
geted at chemical analysis of bioeffective analytes bound to the functional
biomolecules.